<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Echocardiographic evaluation of the mitral valve</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Echocardiographic evaluation of the mitral valve</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Echocardiographic evaluation of the mitral valve</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nelson B Schiller, MD, FACC, FRCP, FASE</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Xiushui Ren, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bryan Ristow, MD, FACC, FASE, FACP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Warren J Manning, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The mitral valve was the first structure to be identified by echocardiography  (<a class="graphic graphic_figure graphicRef79932" href="/z/d/graphic/79932.html" rel="external">figure 1</a>) [<a href="#rid1">1,2</a>]. Technical advances have enabled echocardiography to identify almost any anatomic or functional abnormality of the mitral valve. The appearance of the normal mitral valve and the more commonly encountered mitral valvular abnormalities will be reviewed here.</p><p class="headingAnchor" id="H3140672819"><span class="h1">STAGE OF VALVE DISEASE</span><span class="headingEndMark"> — </span>The 2020 American College of Cardiology/American Heart Association valvular heart disease guidelines categorizes both mitral stenosis and regurgitation into four stages based on valve anatomy, symptoms, hemodynamics, and their effects on the left ventricle (LV), atrium, and pulmonary circulation [<a href="#rid3">3</a>]. Stage A defines patients at risk, stage B defines progressive valve disease, stage C defines asymptomatic severe disease, and stage D defines symptomatic severe disease  (<a class="graphic graphic_table graphicRef95916" href="/z/d/graphic/95916.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef114438" href="/z/d/graphic/114438.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef97546" href="/z/d/graphic/97546.html" rel="external">table 3</a>).</p><p>Accurate diagnosis and management of mitral valve disease is most robust when based on sequential confirmatory studies, given inherent measurement variability and limitations of each study. In addition, the onset of symptom change may indicate a change in the heart’s response to valve disease, often necessitating a repeat echocardiogram.</p><p>A transthoracic echocardiogram (TTE) is generally the initial test to evaluate the mitral valve. If there is a clinical finding not explained by TTE, or if better visualization or measurements are needed, a transesophageal echocardiogram (TEE) is indicated.</p><p class="headingAnchor" id="H2"><span class="h1">NORMAL MITRAL VALVE</span><span class="headingEndMark"> — </span>A standard TTE examination of the mitral valve consists of an M-mode tracing, multiple two-dimensional (2D) views, and Doppler flow evaluation. Together, these elements form an integrated examination of the mitral valve that can reliably define its function and evaluate the severity of abnormalities [<a href="#rid4">4</a>].</p><p>Anatomically, the orientation of the anterior leaflet of the mitral valve places this broad surface toward the anterior chest wall, making it an ideal sound reflecting target on TTE. Furthermore, because of its relatively large margin-to-base ratio, the anterior leaflet is highly mobile  (<a class="graphic graphic_figure graphicRef57906" href="/z/d/graphic/57906.html" rel="external">figure 2</a>).</p><p>The mitral valve can be recorded by ultrasound through a variety of anatomic windows in the precordium, apical, and subxiphoid regions, all of which should be used in its examination.</p><p class="headingAnchor" id="H3"><span class="h2">M-mode echocardiogram</span><span class="headingEndMark"> — </span>The M-mode examination is performed from the precordium and guided from the 2D long and short axis views. Normally, the anterior mitral leaflet exhibits a motion pattern that reflects the phasic nature of ventricular filling and produces a familiar M-shaped pattern  (<a class="graphic graphic_figure graphicRef67656" href="/z/d/graphic/67656.html" rel="external">figure 3</a>). The posterior leaflet moves in a nearly mirror image "W" pattern with a smaller excursion.</p><p class="bulletIndent1"><span class="glyph">●</span>The initial large opening diastolic movement of the valve, which culminates in the E-point, is the result of rapid LV filling.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The valve assumes a nearly closed position during the middle of diastole (F point), reflecting the deceleration of inflow as the pressure gradient between atrium and ventricle is reduced. On the M-mode echocardiogram, this mid-diastolic closure is measured as the E-F slope, which is usually &gt;60 mm/s.</p><p></p><p class="bulletIndent1">During this mid-diastolic phase, in spite of the appearance of closure, there continues to be flow of blood from pulmonary veins to the LV. This period of filling is known as the conduit phase because the atrium briefly functions as a passive channel rather than a reservoir [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Following atrial contraction, the valve opens for a second time (A point), completing the second peak of the letter M.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Final closure is probably the combined effect of deceleration of atrial inflow and isometric LV contraction.</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Two-dimensional echocardiogram</span><span class="headingEndMark"> — </span>The 2D appearance of the normal mitral valve on TTE depends somewhat upon the imaging plane from which it is viewed. In the parasternal short axis plane, the valve presents itself as an ovoid (fish mouth) orifice  (<a class="graphic graphic_diagnosticimage graphicRef68826" href="/z/d/graphic/68826.html" rel="external">image 1</a>), while in parasternal long axis and apical views, it resembles clapping hands, with the anterior hand longer and more mobile than the posterior  (<a class="graphic graphic_diagnosticimage graphicRef77446 graphicRef75034" href="/z/d/graphic/77446.html" rel="external">image 2A-B</a>). In general, the normal mitral valve should appear as a mobile, two leaflet structure that moves freely enough to respond to the normal flux of diastolic filling but forms a stable coaptation plane in systole without breaking the plane defined by the mitral annulus and entering the body of the left atrium.</p><p>Anatomically, the mitral valve leaflets are thin and translucent; the rough attachment points of its chordae to their free margins are thicker than their smooth bellies. The chordae from each leaflet connect to both papillary muscles. On M-mode, each leaflet is represented by no more than two linear echoes. On 2D imaging, the valve appears homogeneous and thin, &lt;4 mm in thickness. However, the perception of leaflet thickness also depends upon the transducer frequency.</p><p>Many sonographers prefer 2.5 mHz for imaging because it allows adequate images in difficult patients and is superior for Doppler flow. At this lower frequency, some normal valves can appear mildly thickened. For this reason, if an abnormality is suspected, the valve should be imaged with a higher frequency before being designated as "thickened." In order to exclude valve pathology, fundamental (non-harmonic) imaging at 3.5 mHz or higher should be used. As a general rule, when imaged fundamentally, a normal mitral valve is thinner than a normal aortic root imaged under the same conditions.</p><p>Other anatomic features of the mitral apparatus that are appreciated on 2D echocardiographic examination include the papillary muscles, chordae, and the mitral annulus.</p><p class="bulletIndent1"><span class="glyph">●</span>The papillary muscles can be seen in the parasternal short axis at approximately four o'clock (anterolateral) and eight o'clock (posteromedial) orientations, and their fine anatomy is highly variable.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The mitral annulus is receiving increasing attention because three-dimensional (3D) imaging has revealed it to be highly dynamic [<a href="#rid6">6</a>]. On 2D imaging, the examination is limited to measuring the diameter of the mitral annulus and inspecting it for calcification  (<a class="graphic graphic_diagnosticimage graphicRef60748" href="/z/d/graphic/60748.html" rel="external">image 3</a> and <a class="graphic graphic_diagnosticimage graphicRef61639" href="/z/d/graphic/61639.html" rel="external">image 4</a> and <a class="graphic graphic_waveform graphicRef56296" href="/z/d/graphic/56296.html" rel="external">waveform 1</a>).</p><p></p><p class="bulletIndent1">Mitral annulus disjunction is an abnormal atrial displacement of the mitral valve leaflet hinge point away from the ventricle (into the atrium). This abnormality of the mitral annulus is associated with mitral valve prolapse and increased ventricular arrhythmias [<a href="#rid7">7</a>].</p><p></p><p>Mitral leaflet anatomy can be identified by location on standard imaging views. In the parasternal long axis, the A2 and P2 segments are visualized. A1 and P1 segments are adjacent to the left atrial appendage, which is seen on the right side of the image in the standard parasternal short-axis view (with the near field at the top of the image). In the two-chamber view, segments P1, A2, and P3 are visualized from right to left in the transthoracic image, with P1 adjacent to the anterior annulus.</p><p class="headingAnchor" id="H2190322913"><span class="h2">Transesophageal echocardiogram</span><span class="headingEndMark"> — </span>Because the esophagus is situated directly posterior and adjacent to the left atrium, TEE generally provides superior visualization of the mitral apparatus compared with TTE. By TEE in the zero-degree plane, A1 and P1 are seen first as the probe is advanced; with deeper insertion, A2 and P2 come into view, and subsequently A3 and P3 are visualized. In the midesophageal commissural view (45 to 90 degrees), all six segments of the valve leaflets can be visualized by turning the probe clockwise and counterclockwise. Finally, in the long-axis view (120 to 150 degrees), all segments can again be visualized. By comprehensively examining all segments from different planes, mitral valve lesions can be accurately localized and characterized [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Doppler echocardiogram</span><span class="headingEndMark"> — </span>Doppler examination of the normal mitral valve reveals that the velocity pattern of blood entering the LV during diastole closely resembles the M-shaped pattern of the M-mode of that structure; blood flow is most rapid during the early (E) phases of filling, falls to very low levels during the mid-diastolic conduit phase, and accelerates again during atrial (A) contraction. Transmitral flow is sampled from the apical four chamber view; the sampling site used to obtain this signal is the space between the tips of the open mitral valve  (<a class="graphic graphic_waveform graphicRef59321" href="/z/d/graphic/59321.html" rel="external">waveform 2</a>). When transmitral flow is used to quantitate flow volume, the sample volume is placed in the mitral annulus. The normal peak flow velocity across the mitral valve is usually just under 1 m/s and the normal mitral valve area is 4 to 6 cm<sup>2</sup>.</p><p>Many measurements are derived from the transmitral wave form. The most reliable and relevant measurements are the ratio of the E to A waves, the isovolemic relaxation time, and the deceleration time. These values give insight into diastolic function and into the function of the valve.</p><p class="headingAnchor" id="H109550740"><span class="h2">Three-dimensional echocardiogram</span><span class="headingEndMark"> — </span>Three-dimensional echocardiography has improved the understanding of the anatomy and function of the hyperbolic paraboloid mitral valve. Three-dimensional TTE image acquisition is performed from the parasternal and apical views, using zoomed or full-volume feature. Changing the display enables visualization of the mitral valve from either the LV or the left atrium ("surgical") perspective and allows for precise lesion localization. Additionally, 3D echocardiography allows for accurate LV measurements as it avoids LV foreshortening [<a href="#rid9">9</a>]. Subvalvular apparatus can be seen from the LV perspective  (<a class="graphic graphic_movie graphicRef94912" href="/z/d/graphic/94912.html" rel="external">movie 1</a>) [<a href="#rid10">10</a>]. Three-dimensional TEE has superior resolution compared with 3D TTE and is a critical aid in percutaneous mitral valve repair [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H1283768572"><span class="h2">Stress echocardiogram</span><span class="headingEndMark"> — </span>In patients whose symptoms and valve severity are discordant, stress echocardiography can be critical in determining stage of disease and timing of management. In patients with equivocal or minimal symptoms, stress testing can help identify those who are truly symptomatic. Conversely, in patients with symptoms out of proportion to the severity of valve disease, stress testing can help diagnose other causes of symptoms (such as arrhythmia).</p><p class="headingAnchor" id="H6"><span class="h1">MITRAL VALVE LESIONS CAUSING INFLOW OBSTRUCTION</span><span class="headingEndMark"> — </span>The most common lesion of the mitral valve that causes inflow obstruction is mitral stenosis (MS), which is usually acquired as the result of rheumatic heart disease. Less common causes include left atrial myxoma and other tumors, severe mitral annular calcification, left-sided carcinoid heart disease, and congenital disorders. (See  <a class="medical medical_review" href="/z/d/html/8173.html" rel="external">"Rheumatic mitral stenosis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/8135.html" rel="external">"Carcinoid heart disease"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Mitral stenosis</span><span class="headingEndMark"> — </span>In MS, the normal, rapid, biphasic motion of the valve is altered because the valve opens only partly and as a single unit. Anatomically, the commissural separation between the anterior and posterior or mural leaflets is diminished by partial fusion and the subvalvular apparatus is altered by chordal foreshortening. Immobility of the posterior leaflet is a common early finding with a "hockey stick/knee bend" appearance to the anterior mitral leaflet due to leaflet tethering. Doming of the anterior leaflet corresponds temporally to the opening snap on auscultation.</p><p>These changes cause a limiting orifice that obstructs diastolic transit of blood from atrium to ventricle. One hemodynamic consequence of this alteration is a holodiastolic pressure gradient between the left atrium and LV.</p><p>TTE can identify the pathologic entity of MS and quantitate its severity with sufficient accuracy to make reliable decisions about the suitability for catheter-based balloon valvotomy or the need for surgery. Quantitation of MS severity can be accomplished by direct methods and its qualitative estimation by a number of indirect observations  (<a class="graphic graphic_table graphicRef97546" href="/z/d/graphic/97546.html" rel="external">table 3</a>).</p><p class="headingAnchor" id="H8"><span class="h3">M-mode echocardiography</span><span class="headingEndMark"> — </span>M-mode confirmation of the altered pattern of mitral motion in MS remains a useful tool. MS alters the appearance of the M-mode tracing of the mitral valve so that its normal early diastolic closure is delayed or abolished. The early diastolic closure slope, the E-F slope, produces an easily recognized pattern and can also be quantitated to separate normal atrial inflow from obstructed and to differentiate among the degrees of obstruction  (<a class="graphic graphic_figure graphicRef73666 graphicRef57949 graphicRef65631" href="/z/d/graphic/73666.html" rel="external">figure 4A-C</a> and <a class="graphic graphic_movie graphicRef50915" href="/z/d/graphic/50915.html" rel="external">movie 2</a>). Although this method is the least reliable means of quantitating the severity of obstruction, a slope of less than 10 mm/s (normal is &gt;60 mm/s) from a valve recording made during suspended respiration is evidence for severe MS [<a href="#rid12">12</a>]. In normal valves, the posterior leaflet moves in a mirror image pattern to the anterior; in MS, the posterior leaflet moves forward in diastole, paralleling the anterior. Reversal of diastolic motion from the normal pattern makes the M-mode of the posterior leaflet one of the most valuable means of identifying MS. </p><p>The opening snap (OS) of the mitral valve coincides with the initial peak opening (E) of the valve  (<a class="graphic graphic_picture graphicRef73087" href="/z/d/graphic/73087.html" rel="external">picture 1</a>).</p><p class="headingAnchor" id="H9"><span class="h3">Two-dimensional TTE</span><span class="headingEndMark"> — </span>MS alters the appearance of the valve on 2D echocardiography because it partially fuses the normally independent leaflets and creates a persistent gradient between the LV and left atrium. This gradient keeps the stenotic diastolic orifice opened to its maximum and causes the entire valve to dome or bulge into the ventricle throughout diastole  (<a class="graphic graphic_diagnosticimage graphicRef71983" href="/z/d/graphic/71983.html" rel="external">image 5</a> and <a class="graphic graphic_movie graphicRef78565" href="/z/d/graphic/78565.html" rel="external">movie 3</a> and <a class="graphic graphic_movie graphicRef62748" href="/z/d/graphic/62748.html" rel="external">movie 4</a> and <a class="graphic graphic_movie graphicRef71501" href="/z/d/graphic/71501.html" rel="external">movie 5</a>). The elevated gradient initiates the opening motion in an abrupt manner, generating the opening snap and a characteristic "knee bend" appearance on the precordial long axis view  (<a class="graphic graphic_diagnosticimage graphicRef73951" href="/z/d/graphic/73951.html" rel="external">image 6</a> and <a class="graphic graphic_movie graphicRef76132" href="/z/d/graphic/76132.html" rel="external">movie 6</a>).</p><p>In the parasternal short axis plane, the opening of the valve can be imaged just above the tips of the papillary muscles. From this orientation, its maximum diastolic opening area can be measured by direct planimetry of the 2D image. This method is a reliable means of judging the severity of obstruction [<a href="#rid12">12,13</a>]. A mitral valve area (MVA) of less than 1.0 cm<sup>2</sup> is considered severe, regardless of the method used to calculate its size.</p><p>Other features of MS on the 2D echocardiogram include chordal foreshortening and atrial thrombi; the latter are rarely seen in echocardiograms taken from the precordial windows.</p><p class="headingAnchor" id="H10"><span class="h3">Doppler echocardiography</span><span class="headingEndMark"> — </span>Doppler methods provide a constellation of measurements by which the severity of MS is gauged. These variables include the gradient across the valve at rest and with exercise, the inferred area by the pressure half-time method, the continuity equation or the proximal flow convergence method, and the pulmonary pressure at rest and during exercise from the tricuspid regurgitant jet velocity [<a href="#rid14">14-16</a>].</p><p>Doppler methods can measure the velocity of mitral inflow. In MS, this velocity increases at rest from a normal value of less than 1 m/s to greater than 1.5 m/s. The algorithm to convert Doppler velocity into pressure gradient is the modified Bernoulli equation. The peak gradient between two reservoirs connected by a narrow orifice or pipe (in this case the LV and the left atrium connected by the stenotic mitral valve) can be calculated by the modified Bernoulli formula, taking the square of the peak velocity of fluid flowing between them (in this case, blood) and multiplying by four  (<a class="graphic graphic_movie graphicRef68524" href="/z/d/graphic/68524.html" rel="external">movie 7</a> and <a class="graphic graphic_movie graphicRef52554" href="/z/d/graphic/52554.html" rel="external">movie 8</a> and <a class="graphic graphic_waveform graphicRef52855" href="/z/d/graphic/52855.html" rel="external">waveform 3</a>).</p><div class="formulaContainer"><div class="formula"><p>  Peak gradient, in mmHg  =  4  x  (peak velocity)<sup>2</sup></p></div></div><p>Thus, a peak velocity of 1 m/s indicates a peak gradient of 4 mmHg; a peak velocity of 2 m/s indicates a peak gradient of 16 mmHg; 3 m/s indicates a peak gradient of 36 mmHg.</p><p>The mean transmitral gradient (TMG) can be measured by tracing the area-under-the-curve of the mitral E and A waves obtained by continuous wave Doppler. With severe MS, the mean TMG is &gt;10 mmHg in sinus rhythm at heart rates (HR) between 60 and 80 beats per minute [<a href="#rid17">17</a>].</p><p>MS severity can be challenging to determine, especially in the presence of calcific stenosis, because gradients are influenced by HR and stroke volume (SV). As such, a simplified formula for projected TMG was found to be more accurate than TMG alone [<a href="#rid18">18</a>]:</p><div class="formulaContainer"><div class="formula"><p>  Projected TMG  =  TMG  -  0.07  (HR  -  70)</p></div></div><p>This formula incorporates HR data obtained during echocardiography and predicts adverse events better than TMG alone.</p><p>The most frequently used measurement for the determination of the mitral valve area is the pressure half-time, which is derived from hemodynamic data  (<a class="graphic graphic_figure graphicRef65636 graphicRef64364" href="/z/d/graphic/65636.html" rel="external">figure 5A-B</a>). The pressure half-time is the time required for the gradient between the left atrium and the LV to fall to one-half of its initial value. In order to convert Doppler velocity into a pressure gradient, the initial flow velocity is divided by 1.41 (square root of 2), because velocity bears a second order relationship to pressure. Empirically, a pressure half-time of 220 ms is equivalent to a valve area of 1.0 cm<sup>2</sup>; therefore:</p><div class="formulaContainer"><div class="formula"><p>  MVA  =  220  /  pressure half-time</p></div></div><p>Calculating the MVA using the pressure half-time may be an inaccurate approach whenever abrupt changes in the TMG occur for reasons other than inflow obstruction. An example of such a change is additional ventricular filling from aortic regurgitation.</p><p>Among the methods for estimating rheumatic MS severity, direct planimetry of the orifice is probably the most accurate when performed correctly with good image quality and without severe distortion of valve anatomy [<a href="#rid17">17</a>]. However, in a clinical setting, limitations are frequently present and it is the universal practice to achieve cross validation by applying the full array of methods.</p><p>Indirect methods to identify the severity of MS include observing the degree of foreshortening of the chordae tendineae, estimating the extent of leaflet calcification, noting the degree of left atrial enlargement, noting the degree of LV underloading (ie, volume decrease), noting the presence of right ventricular and atrial dilatation, and noting the degree of tricuspid regurgitation and pulmonary hypertension, as determined by Doppler of tricuspid regurgitant jet.</p><p>The 2020 American College of Cardiology/American Heart Association (ACC/AHA) guideline for valvular heart disease defined severe MS as having an MVA ≤1.5 cm<sup>2 </sup>(MVA ≤1.0 cm<sup>2</sup> with very severe MS) and diastolic pressure half-time ≥150 ms (diastolic pressure half-time ≥220 ms with very severe MS), along with severe left atrial enlargement and pulmonary artery systolic pressure &gt;50 mmHg  (<a class="graphic graphic_table graphicRef97546" href="/z/d/graphic/97546.html" rel="external">table 3</a>) [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H11"><span class="h3">Stress echocardiography</span><span class="headingEndMark"> — </span>Documentation of elevation of TMG and pulmonary pressure during exercise is useful in patients whose symptoms do not seem concordant with the degree of MS at rest [<a href="#rid3">3</a>]. In patients who cannot exercise, <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">dobutamine</a> has been used to increase heart rate [<a href="#rid19">19</a>]. The 2020 ACC/AHA valve guideline recommended exercise echocardiography in evaluating the severity of MS when there is a discrepancy between the resting echocardiographic findings and clinical findings [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/5310.html" rel="external">"Overview of stress echocardiography", section on 'Indications'</a>.)</p><p class="headingAnchor" id="H12"><span class="h3">Three-dimensional echocardiography</span><span class="headingEndMark"> — </span>Three-dimensional echocardiography has been evaluated for its utility in assessing MS [<a href="#rid20">20,21</a>]. This technique can provide an en-face cross sectional view of the mitral orifice, to which planimetry can be applied to determine the MVA. Compared with 2D echocardiography, it performs better when cardiac catheterization-derived MVA is used as the reference standard. Three-dimensional echocardiography has also been used to characterize mitral leaflet motion in hypertrophic obstructive cardiomyopathy. Specifically, it has demonstrated the long mitral leaflets protruding into the LV outflow tract and the resulting mitral regurgitant orifice, the so-called "dolphin smile" phenomenon [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/5322.html" rel="external">"Three-dimensional echocardiography", section on 'Valvular heart disease'</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Echocardiography in balloon valvuloplasty</span><span class="headingEndMark"> — </span>The role of echocardiography in MS has become even more demanding with the development of catheter-based palliative interventions. These interventions require a transseptal puncture to deliver a dilating balloon across the obstructed mitral orifice. When successful, these techniques offer dramatic relief of symptoms and may avoid surgery. (See  <a class="medical medical_review" href="/z/d/html/8161.html" rel="external">"Percutaneous mitral balloon commissurotomy in adults"</a>.)</p><p>The likelihood of success of balloon valvotomy can be judged with TTE by grading the severity of involvement of elements of the mitral valve on scale of 1 through 4, with a score of 1 representing normal [<a href="#rid23">23,24</a>]. The four elements are the mobility of the anterior leaflet, the severity of subvalvular disease, the calcification of the anterior leaflet, and the thickness of the anterior leaflet. The value for each of these four scores is added together for a total "splitability index" of 4 to 16, with a score of 8 or less indicating a higher probability of success.</p><p>Other studies have proposed an alternate means of judging suitability for valvotomy by the location and distribution of calcium around the stenotic orifice [<a href="#rid25">25</a>]. Mitral regurgitation (MR) is not included in any of these indices, but a degree of MR more than mild is considered a relative contraindication to the procedure. Indeed, severe MR, occurring as a complication of the procedure, often requires urgent valve replacement.</p><p class="headingAnchor" id="H14"><span class="h2">Mitral annular calcification</span><span class="headingEndMark"> — </span>Mitral annular calcification is a common echocardiographic finding associated with aging, renal failure and other conditions. It is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/8122.html" rel="external">"Clinical manifestations and diagnosis of mitral annular calcification"</a>.)</p><p class="headingAnchor" id="H15"><span class="h2">Other</span><span class="headingEndMark"> — </span>Congenital conditions that cause MS are rarely encountered in adults. Parachute mitral valve (single papillary muscle), supravalvular mitral ring, and cor triatriatum are congenital conditions that obstruct mitral inflow.</p><p class="headingAnchor" id="H16"><span class="h3">Cor triatriatum</span><span class="headingEndMark"> — </span>Cor triatriatum is among the rarest of all congenital cardiac anomalies and is often a hemodynamically mild incidental finding. The membrane of cor triatriatum appears as a linear echo bisecting the left atrium, from right to left, into an upper chamber (embryonic common pulmonary vein) containing the pulmonary veins and a lower chamber (embryonic left atrium) leading to the mitral inflow tract. Color flow mapping usually demonstrates mild increases in velocity, suggesting minimal obstruction. This lesion may be resected in childhood, as it may eventually lead to atrial dilation and symptomatic arrhythmia.</p><p class="headingAnchor" id="H17"><span class="h3">Left atrial myxoma</span><span class="headingEndMark"> — </span>Left atrial myxoma, when mobile, may cause inflow obstruction by interposing its bulk in the mitral orifice  (<a class="graphic graphic_movie graphicRef53539" href="/z/d/graphic/53539.html" rel="external">movie 9</a> and <a class="graphic graphic_movie graphicRef80469" href="/z/d/graphic/80469.html" rel="external">movie 10</a> and <a class="graphic graphic_movie graphicRef58730" href="/z/d/graphic/58730.html" rel="external">movie 11</a> and <a class="graphic graphic_movie graphicRef71550" href="/z/d/graphic/71550.html" rel="external">movie 12</a> and <a class="graphic graphic_movie graphicRef73495" href="/z/d/graphic/73495.html" rel="external">movie 13</a>). When these rare tumors are encountered on 2D imaging, Doppler examination detects the degree of mechanical inflow obstruction. (See  <a class="medical medical_review" href="/z/d/html/4881.html" rel="external">"Cardiac tumors"</a> and  <a class="medical medical_review" href="/z/d/html/5303.html" rel="external">"Echocardiography in detection of cardiac and aortic sources of systemic embolism"</a>.)</p><p class="headingAnchor" id="H18"><span class="h3">Other cardiac tumors</span><span class="headingEndMark"> — </span>Primary malignant tumors of the heart, such as angiosarcomas and lymphomas, may mechanically deform and obstruct the mitral valve. Advanced lymphoma may engulf much of the mitral apparatus. (See  <a class="medical medical_review" href="/z/d/html/4881.html" rel="external">"Cardiac tumors"</a>.)</p><p class="headingAnchor" id="H19"><span class="h3">Carcinoid heart disease</span><span class="headingEndMark"> — </span>Carcinoid heart disease is a rare disease that, in most patients, involves only valves on the right side of the heart. However, left-sided involvement (MS) can occur when there are bronchial metastases [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/z/d/html/8135.html" rel="external">"Carcinoid heart disease"</a>.)</p><p class="headingAnchor" id="H20"><span class="h1">ABNORMALITIES ASSOCIATED WITH MITRAL REGURGITATION</span></p><p class="headingAnchor" id="H2066686997"><span class="h2">Acute mitral regurgitation</span><span class="headingEndMark"> — </span>Sudden disruption of the mitral apparatus (eg, leaflet perforation from infective endocarditis, chordal rupture from myxomatous disease, papillary muscle rupture from acute myocardial infarction) can result in acute severe mitral regurgitation (MR). In acute MR, the left atrium and ventricle have not had enough time to remodel. Thus, the acute volume overload leads to pulmonary edema and reduced cardiac output. On physical exam, the murmur is often short or absent. Color Doppler may show laminar flow, and regurgitation can be missed. Assessment of mitral inflow using continuous wave Doppler and looking for pulmonary vein flow reversal are often keys to echocardiographic diagnosis of severe acute MR.</p><p class="headingAnchor" id="H675073039"><span class="h2">Chronic primary mitral regurgitation</span><span class="headingEndMark"> — </span>Whereas stenotic lesions alter the diastolic motion pattern of the mitral valve and are readily identifiable by M-mode and 2D imaging, lesions associated with MR are often associated with subtle abnormalities of the valve elements. However, when the valve is obviously disrupted or partially flail, MR is likely to be severe  (<a class="graphic graphic_movie graphicRef65945" href="/z/d/graphic/65945.html" rel="external">movie 14</a> and <a class="graphic graphic_movie graphicRef65137" href="/z/d/graphic/65137.html" rel="external">movie 15</a> and <a class="graphic graphic_movie graphicRef57557" href="/z/d/graphic/57557.html" rel="external">movie 16</a> and <a class="graphic graphic_waveform graphicRef80563" href="/z/d/graphic/80563.html" rel="external">waveform 4</a>). Competent mitral leaflets typically have a coaptation surface (coaptation length) of 8 to 10 mm (compared with 4 to 9 mm for tricuspid valve) [<a href="#rid27">27</a>]. While 2D TTE is not accurate in measuring coaptation surface, 3D TEE or cardiac magnetic resonance imaging is more reliable [<a href="#rid27">27</a>].</p><p>In contrast to anatomic imaging methods, Doppler flow imaging is highly sensitive in detecting MR of all severities and is the most important part of the ultrasound examination for MR. In addition, echocardiographic assessment should include evaluation of regurgitation (particularly when clinically significant) and should include identification of the mechanism and possible etiology, as this affects the severity of regurgitation, cardiac remodeling, and management, as noted in the 2017 American Society of Echocardiography (ASE) guidelines for evaluation of native valvular regurgitation [<a href="#rid27">27</a>]. A precise description of the lesions, using segmental and functional anatomy according to the Carpentier classification [<a href="#rid28">28</a>], should be performed to determine disease severity and assess the feasibility of repair  (<a class="graphic graphic_table graphicRef95916" href="/z/d/graphic/95916.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H21"><span class="h2">Determination of severity</span><span class="headingEndMark"> — </span>Over 20 variables for judging the severity of MR have been described [<a href="#rid4">4</a>]. Employing this approach, severe lesions are readily recognized, but distinguishing among the intermediate grades of MR (mild to moderate, moderate to severe MR) is more difficult.</p><p>The 2017 ASE consensus statement on echocardiographic quantification of valvular regurgitation [<a href="#rid27">27</a>], corroborated by the 2020 American College of Cardiology/American Heart Association (ACC/AHA) valve guideline [<a href="#rid3">3</a>], recommended using multiple parameters when determining the severity of MR  (<a class="graphic graphic_table graphicRef95916" href="/z/d/graphic/95916.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef114438" href="/z/d/graphic/114438.html" rel="external">table 2</a>). These include structural, qualitative Doppler, and quantitative Doppler parameters. In addition, TTE enables measurement of mitral annular dimensions and identification of calcification.</p><p>Achieving reliability in grading the severity of MR is challenging [<a href="#rid29">29</a>]. We recommend quantifying multiple parameters and integrating the results over serial studies.</p><p>To further differentiate moderate from severe regurgitation, it is frequently useful to perform supine bicycle exercise to evaluate for an exaggerated rise in pulmonary pressure, which typifies the more advanced degrees of MR [<a href="#rid30">30</a>]. Resting pulmonary artery systolic pressure &gt;50 mmHg is a class IIa indication for intervention by both the ACC and European Society of Cardiology guidelines [<a href="#rid3">3,31</a>]. While exercise-induced increase in pulmonary artery systolic pressure &gt;60 mmHg has been proposed as a criterion for intervention [<a href="#rid32">32</a>], our lab uses &gt;65 mmHg as a cutoff in older patients, as 60 mmHg is at the upper limit of normal during exercise.</p><p class="headingAnchor" id="H22"><span class="h3">Structural parameters</span><span class="headingEndMark"> — </span>Structural abnormalities associated with MR supplement the quantitation of regurgitation and include left atrial size, LV size, and appearance of the mitral apparatus.</p><p class="bulletIndent1"><span class="glyph">●</span>Mild MR is usually associated with normal or near-normal left atrial size, LV size, and intact mitral apparatus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moderate MR is frequently associated with some degree of left atrial enlargement, normal or mildly dilated LV, and varying degrees of mitral apparatus abnormalities.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe chronic MR is usually associated with moderate to severe left atrial enlargement, some degree of LV dilatation, and often associated with flail mitral leaflet, ruptured papillary muscle, or malcoaptation of the mitral leaflets. Ultimately, reduced LV systolic function will occur if severe MR is left untreated. Frequently after mitral valve intervention, LV systolic function will be lower due to removal of a low pressure "pop-off" valve (the left atrium).</p><p></p><p class="headingAnchor" id="H23"><span class="h3">Color flow Doppler</span><span class="headingEndMark"> — </span>The features of severe MR seen by color flow Doppler imaging arise from the high energy transfer of a volume of blood into the left atrium, producing the characteristic "jet" in the left atrium  (<a class="graphic graphic_movie graphicRef75955" href="/z/d/graphic/75955.html" rel="external">movie 17</a> and <a class="graphic graphic_movie graphicRef63107" href="/z/d/graphic/63107.html" rel="external">movie 18</a> and <a class="graphic graphic_movie graphicRef78402" href="/z/d/graphic/78402.html" rel="external">movie 19</a> and <a class="graphic graphic_movie graphicRef61846" href="/z/d/graphic/61846.html" rel="external">movie 20</a> and <a class="graphic graphic_diagnosticimage graphicRef76485" href="/z/d/graphic/76485.html" rel="external">image 7</a>) [<a href="#rid33">33</a>]. Color flow Doppler is usually considered a qualitative or semi-quantitative parameter.</p><p class="bulletIndent1"><span class="glyph">●</span>In current practice, it is common to judge a small jet occupying less than 20 percent of the left atrial area as mild, a middle-sized jet as moderate, and a large jet (more than 40 percent and extending into the pulmonary veins) as severe MR. However, these jets are very sensitive to instrument settings, and the size of a color jet may be misleading; thus, reliance on these size judgments alone is imprudent [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>On the ventricular side of the valve, proximal flow acceleration (proximal isovelocity surface area or PISA) is seen as a concentric series of hemispheric shells of alternating colors, each shell denoting an isovelocity of aliasing [<a href="#rid34">34</a>]. The diameter of the ring closest to the regurgitant orifice is measured and, in severe MR, usually approaches 1 cm. (See <a class="local">'Quantitative parameters of mitral regurgitation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After the color jet crosses the valve defect, the width of the jet increases. In the parasternal long-axis view, the narrowest portion of the regurgitant jet across the valve is defined as the vena contracta. Mild MR is usually associated with a vena contracta less than 0.3 cm, while severe MR is usually associated with a vena contracta of 0.7 cm or more [<a href="#rid35">35,36</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>As the jet of severe MR enters the left atrium, it becomes eccentric and hugs the wall of the chamber (entrainment or Coanda effect). Once entrained on the wall, the jet may completely circle the chamber. The jet also tends to penetrate the atrial appendage and one or more of the pulmonary veins. The color flow pattern in the receiving chamber is agitated and multidirectional, and spontaneous contrast is absent. During most of the jet's passage around the atrium, it is broad and aliased. It must be emphasized that any aliased (mosaic) wall hugging jet, however small in apparent area, should be considered to potentially represent severe MR. Generally, milder degrees of MR are associated with central jets that lose their mosaic pattern before reaching the atrial wall.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some researchers have found the jet area in the left atrium on TEE to be a useful guide to MR severity [<a href="#rid33">33</a>]. However, since the entire left atrium cannot be seen at one time, the measurement of total jet size is problematic. Furthermore, careful study of most jets with appropriate frame rates reveals that they are not central jets but entrained wall jets, which do not lend themselves to "jet area measurement." We do not endorse this method.</p><p></p><p class="headingAnchor" id="H24"><span class="h3">Pulsed and continuous wave Doppler of mitral inflow</span><span class="headingEndMark"> — </span>Spectral Doppler (pulsed and continuous wave) recognition of severe MR also has many diagnostic features. In severe MR, the early diastolic mitral inflow pulsed-wave Doppler signal wave (E wave), obtained at the tips of the mitral leaflets, is almost always increased to greater than 1.4 m/s  (<a class="graphic graphic_figure graphicRef66504 graphicRef76117" href="/z/d/graphic/66504.html" rel="external">figure 6A-B</a>) [<a href="#rid37">37</a>].</p><p>In addition to increased peak transmitral inflow E wave velocity, the pattern is strongly E-wave dominant with a small A-wave (E/A ratio greater than 2.0). This pattern is identical to the restrictive inflow pattern and has a similar origin, in that filling pressures may be elevated in both situations. Finding an A-wave dominant pattern of mitral inflow makes severe MR very unlikely.</p><p>Several features of the continuous wave Doppler systolic patterns of regurgitant mitral flow support the presence of severe MR. Because density of the continuous wave jet is proportional to the number of red blood cells reflecting sound, severe MR usually has a dense continuous wave jet. The average pixel intensity of the continuous wave Doppler jet has been found to be correlated with outcome [<a href="#rid38">38</a>]. However, it is important to note that jet density is gain dependent. In addition, eccentric jets can be less dense even though the regurgitation is severe [<a href="#rid27">27</a>]. If the flow signal can be aligned parallel to the beam, the jet will appear uniformly dense throughout its duration, have a well-defined envelope, and may, in its late phases, show evidence of a "v-wave cut-off sign." This sign results from a rapid decrease in ventriculoatrial gradient as the large volume of regurgitant blood abruptly raises pressure in the left atrium  (<a class="graphic graphic_waveform graphicRef51062" href="/z/d/graphic/51062.html" rel="external">waveform 5</a>).</p><p class="headingAnchor" id="H25"><span class="h3">Quantitative parameters of mitral regurgitation</span><span class="headingEndMark"> — </span>Using the PISA method and various volumetric methods, quantitative measures including regurgitant volume, regurgitant fraction, and effective regurgitation orifice area (EROA) can be calculated [<a href="#rid27">27</a>].</p><p>Color flow imaging displays the convergence signal known as PISA as a hemispheric shell with surface velocity equal to the chosen aliasing velocity (Va) [<a href="#rid39">39</a>]. At a given aliasing velocity, the radius (r) of PISA increases with increasing regurgitant volume. The EROA can be calculated by dividing the flow rate through the regurgitant orifice (which is estimated as the product of the surface area of the hemisphere [2πr<sup>2</sup>] and Va) by the peak velocity of the regurgitant jet (PkVreg):</p><div class="formulaContainer"><div class="formula"><p>  EROA  =  (2πr<sup>2</sup>  x  Va)  /  PkVreg</p></div></div><p>PISA has been extensively studied as a moderately accurate means of quantifying severity of MR [<a href="#rid34">34</a>]. Limitations of PISA include reduced accuracy for eccentric jets and, compared with central jets, difficulty in identifying the regurgitant orifice and inaccurate estimation of the convergence shape [<a href="#rid40">40</a>]. Performed correctly, these parameters are considered most accurate because they are objective. However, measurements must be performed carefully by experienced sonographers. For example, the PISA signal must not impinge on a chamber wall in order to retain accuracy [<a href="#rid39">39</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Mild MR is associated with regurgitant volume, regurgitant fraction, and EROA of less than 30 mL/beat, less than 30 percent, and less than 0.2 cm, respectively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moderate MR is associated with regurgitant volume, regurgitant fraction, and EROA of 30 to 59 mL/beat, 30 to 49 percent, and 0.2 to 0.39 cm, respectively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe MR is associated with regurgitant volume, regurgitant fraction, and EROA of at least 60 mL/beat, at least 50 percent, and at least 0.4 cm, respectively. However, if the LV chamber size is normal, a diagnosis of severe MR should be questioned and reconsidered.</p><p></p><p class="headingAnchor" id="H26"><span class="h3">Doppler of pulmonary veins</span><span class="headingEndMark"> — </span>Doppler interrogation of the pulmonary veins has produced insights into hemodynamics. In MR, this evaluation is a standard part of the examination and usually includes pulse Doppler of the left and right upper pulmonary veins from the apical four-chamber view. Normal pulmonary venous flow is antegrade during both ventricular systole and diastole (ventricular systolic component dominates), with slight retrograde flow during atrial systole. In hemodynamically severe MR, the flow in one or more pulmonary veins (depending upon the direction of the jet) will show systolic flow reversal  (<a class="graphic graphic_diagnosticimage graphicRef62749" href="/z/d/graphic/62749.html" rel="external">image 8</a>) and is the analog of the V wave seen in the left atrial pressure tracing and on a pulmonary artery wedge pressure tracing. After mitral valve intervention, normalization of pulmonary vein flow (an indication of normal left atrial pressure) is a key sign that MR has been reduced to mild [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/z/d/html/8127.html" rel="external">"Hemodynamics of valvular disorders as measured by cardiac catheterization"</a>.)</p><p class="headingAnchor" id="H27"><span class="h3">Index of severity</span><span class="headingEndMark"> — </span>An echocardiographic index of MR severity has been developed and is based on six variables, each scored on a scale of 0 to 3 and then averaged [<a href="#rid42">42</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Color Doppler regurgitant jet width and penetration</p><p class="bulletIndent1"><span class="glyph">●</span>Color Doppler proximal isovelocity surface area diameter</p><p class="bulletIndent1"><span class="glyph">●</span>Continuous wave Doppler characteristics of the regurgitant jet</p><p class="bulletIndent1"><span class="glyph">●</span>Tricuspid regurgitant jet-derived pulmonary artery pressure by continuous wave Doppler</p><p class="bulletIndent1"><span class="glyph">●</span>Pulse wave Doppler pulmonary venous flow pattern</p><p class="bulletIndent1"><span class="glyph">●</span>Left atrial size by 2D echocardiography</p><p></p><p>In the report presenting this index, all patients with mild MR had an index ≤1.7, and all patients with more significant MR had a value of at least 1.8. A value of at least 2.2 identified patients with severe MR with a sensitivity, specificity, and positive predictive value of 90, 88, and 79 percent, respectively.</p><p>A ratio of time velocity integral of mitral inflow (continuous wave Doppler) to the time velocity integral of the LV outflow (pulse wave Doppler) has been proposed to discriminate severe from nonsevere regurgitation and has excellent interobserver agreement and very good correlation with ASE-recommended parameters [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H28"><span class="h1">MITRAL VALVE LESIONS CAUSING MITRAL REGURGITATION</span><span class="headingEndMark"> — </span>The major causes of mitral regurgitation (MR) are mitral valve prolapse, flail mitral valve, endocarditis, functional MR from cardiomyopathy, ischemic heart disease with papillary muscle displacement (previously known as papillary muscle dysfunction), and rheumatic heart disease. (See  <a class="medical medical_review" href="/z/d/html/8116.html" rel="external">"Clinical manifestations and diagnosis of chronic mitral regurgitation"</a> and  <a class="medical medical_review" href="/z/d/html/8170.html" rel="external">"Acute mitral regurgitation in adults"</a>.)</p><p class="headingAnchor" id="H29"><span class="h2">Mitral valve prolapse</span><span class="headingEndMark"> — </span>Echocardiographic diagnosis of mitral valve prolapse is discussed in detail separately (see  <a class="medical medical_review" href="/z/d/html/8172.html" rel="external">"Mitral valve prolapse: Clinical manifestations and diagnosis"</a>). Briefly, leaflet displacement ≥2 mm above the plane of the mitral annulus in long axis 2D echocardiographic views is the accepted criterion for a positive diagnosis of mitral valve prolapse [<a href="#rid3">3</a>]. It is important to note that MR limited to late systole is rarely severe because it is not holosystolic and regurgitant volume is limited.</p><p class="headingAnchor" id="H33"><span class="h2">Flail mitral valve</span><span class="headingEndMark"> — </span>In most cases of flail mitral valve leaflet, the leaflet is only partially flail. One of the most common causes for a flail mitral valve is ruptured chordae tendineae, often associated with mitral valve prolapse, endocarditis, or trauma  (<a class="graphic graphic_movie graphicRef60709" href="/z/d/graphic/60709.html" rel="external">movie 21</a> and <a class="graphic graphic_movie graphicRef61846" href="/z/d/graphic/61846.html" rel="external">movie 20</a>). A less common cause is partial rupture of a papillary muscle in the setting of an acute myocardial infarction. (See  <a class="medical medical_review" href="/z/d/html/79.html" rel="external">"Role of echocardiography in acute myocardial infarction"</a>.)</p><p>Two-dimensional TTE and TEE are the best methods for detecting a flail leaflet. Using the TTE parasternal long axis and apical four chamber views, extension of a portion of the valve into the left atrium in systole, with a portion of the chordae attached at the tip of the valve, is readily seen  (<a class="graphic graphic_movie graphicRef60709" href="/z/d/graphic/60709.html" rel="external">movie 21</a> and <a class="graphic graphic_movie graphicRef61846" href="/z/d/graphic/61846.html" rel="external">movie 20</a>) [<a href="#rid44">44,45</a>].</p><p>Other findings of flail mitral leaflet include noncoaptation of the two leaflets. If the etiology is papillary muscle rupture, the ruptured papillary muscle can occasionally be visualized.</p><p class="headingAnchor" id="H34"><span class="h2">Endocarditis of the mitral valve</span><span class="headingEndMark"> — </span>For establishing a diagnosis of endocarditis, the first target of the echocardiography examination is the identification, characterization, and localization of valvular vegetations. The process integrates circumstantial findings and epiphenomena (eg, endocarditis is a destructive process resulting in pathologic regurgitation) to reach a reasonable conclusion that a given set of echocardiographic observations has identified the pathologic hallmark of endocarditis, the vegetation  (<a class="graphic graphic_movie graphicRef53844" href="/z/d/graphic/53844.html" rel="external">movie 22</a> and <a class="graphic graphic_diagnosticimage graphicRef66283" href="/z/d/graphic/66283.html" rel="external">image 9</a>). Once a vegetation has been identified, a series of criteria can be applied to judge prognosis. The use of echocardiography in the evaluation of endocarditis is described in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5323.html" rel="external">"Role of echocardiography in infective endocarditis"</a>.)</p><p class="headingAnchor" id="H35"><span class="h2">Secondary mitral regurgitation</span><span class="headingEndMark"> — </span>Primary myocardial disease or dilated cardiomyopathy (DCM) is universally associated with some degree of MR (usually mild to moderate) through the agency of spherical LV remodeling, which distorts the alignment of the mitral apparatus, dilates the annulus, and decreases the area of valve apposition. Severe MR can occur in DCM. The response of MR severity to treatment has been used to guide therapy [<a href="#rid46">46,47</a>]. The stages of secondary mitral regurgitation are described in the table  (<a class="graphic graphic_table graphicRef114438" href="/z/d/graphic/114438.html" rel="external">table 2</a>).</p><p class="headingAnchor" id="H36"><span class="h2">Ischemic heart disease</span><span class="headingEndMark"> — </span>Ischemia as a cause of MR is suggested by the presence of regurgitation in a patient with coronary artery disease, frequently with a previous inferior myocardial infarction or a dilated LV  (<a class="graphic graphic_movie graphicRef73594" href="/z/d/graphic/73594.html" rel="external">movie 23</a> and <a class="graphic graphic_movie graphicRef52748" href="/z/d/graphic/52748.html" rel="external">movie 24</a> and <a class="graphic graphic_movie graphicRef54431" href="/z/d/graphic/54431.html" rel="external">movie 25</a>). On 2D echocardiography, there is shortening of the mitral valve apparatus, resulting in failure of the leaflets to close properly or completely; the leaflets often do not reach the level of the mitral annulus [<a href="#rid48">48,49</a>]. Patients with ischemic heart disease may also have MR from annular dilatation (functional MR). A 3D echocardiographic study suggested that it may be possible to differentiate ischemic MR from functional MR in DCM [<a href="#rid50">50</a>]. The pattern of mitral valve deformation was asymmetric in the ischemic MR and symmetric in functional MR; in addition, the LV chamber and mitral annulus were less enlarged in ischemic MR. In this review, we have not used the term "papillary muscle dysfunction" because we believe it to be anachronistic and uninformative. (See  <a class="medical medical_review" href="/z/d/html/102361.html" rel="external">"Chronic secondary mitral regurgitation: General management and prognosis"</a>.)</p><p class="headingAnchor" id="H37"><span class="h2">Rheumatic mitral regurgitation</span><span class="headingEndMark"> — </span>Rheumatic MR is often associated with some degree of mitral stenosis, and the valve area is usually sufficiently reduced to alter its echocardiographic appearance and sufficiently narrowed to separate it readily from normal even when stenosis is minimal. The scarring associated with the rheumatic process usually results in characteristic alterations of valve motion (see <a class="local">'Mitral stenosis'</a> above) on the M-mode echocardiogram.</p><p>On 2D imaging, failure of coaptation can also be seen during systole on a short axis image; its extent is proportional to the severity of regurgitation. Rheumatic MR is the only form of insufficiency to have been quantitated by failure of coaptation  (<a class="graphic graphic_diagnosticimage graphicRef61901" href="/z/d/graphic/61901.html" rel="external">image 10</a>) [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H4084071644"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/115482.html" rel="external">"Society guideline links: Cardiac valve disease"</a>.)</p><p class="headingAnchor" id="H10087049"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Echocardiography is the primary diagnostic modality for evaluation of mitral valve structure and function. (See <a class="local">'Normal mitral valve'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mitral valve obstruction is caused chiefly by rheumatic mitral stenosis (MS). Less common causes include left atrial myxoma and other tumors, severe mitral annular calcification, left-sided carcinoid heart disease, and congenital disorders. (See  <a class="medical medical_review" href="/z/d/html/8173.html" rel="external">"Rheumatic mitral stenosis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/8135.html" rel="external">"Carcinoid heart disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the presence of characteristic valvular and subvalvular structural changes, severe MS is associated with a pressure half-time of &gt;150 ms and valve area less than 1.5 cm<sup>2</sup>  (<a class="graphic graphic_table graphicRef97546" href="/z/d/graphic/97546.html" rel="external">table 3</a>). (See <a class="local">'Doppler echocardiography'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with rheumatic MS, echocardiography enables evaluation of the likelihood of success for percutaneous balloon valvotomy. (See <a class="local">'Echocardiography in balloon valvuloplasty'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Echocardiography enables quantification of the severity of mitral regurgitation  (<a class="graphic graphic_table graphicRef95916" href="/z/d/graphic/95916.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef114438" href="/z/d/graphic/114438.html" rel="external">table 2</a>) and identification of causes including mitral valve prolapse, flail mitral leaflet, endocarditis, ischemic heart disease, functional regurgitation caused by a cardiomyopathy, and rheumatic mitral disease. (See <a class="local">'Abnormalities associated with mitral regurgitation'</a> above and <a class="local">'Mitral valve lesions causing mitral regurgitation'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Edler, I. Ultrasound cardiogram in mitral valve disease. Acta Chir Scand 1956; 111:230.</a></li><li><a class="nounderline abstract_t">Edler I. Ultrasoundcardiography in mitral valve stenosis. Am J Cardiol 1967; 19:18.</a></li><li><a class="nounderline abstract_t">Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143:e72.</a></li><li><a class="nounderline abstract_t">Schiller NB, Foster E, Redberg RF. Transesophageal echocardiography in the evaluation of mitral regurgitation. The twenty-four signs of severe mitral regurgitation. Cardiol Clin 1993; 11:399.</a></li><li><a class="nounderline abstract_t">Gutman J, Wang YS, Wahr D, Schiller NB. Normal left atrial function determined by 2-dimensional echocardiography. Am J Cardiol 1983; 51:336.</a></li><li><a class="nounderline abstract_t">Flachskampf FA, Franke A, Job FP, et al. Three-dimensional reconstruction of cardiac structures from transesophageal echocardiography. Am J Card Imaging 1995; 9:141.</a></li><li><a class="nounderline abstract_t">Dejgaard LA, Skjølsvik ET, Lie ØH, et al. The Mitral Annulus Disjunction Arrhythmic Syndrome. J Am Coll Cardiol 2018; 72:1600.</a></li><li><a class="nounderline abstract_t">Foster GP, Isselbacher EM, Rose GA, et al. Accurate localization of mitral regurgitant defects using multiplane transesophageal echocardiography. Ann Thorac Surg 1998; 65:1025.</a></li><li><a class="nounderline abstract_t">Mor-Avi V, Jenkins C, Kühl HP, et al. Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error. JACC Cardiovasc Imaging 2008; 1:413.</a></li><li><a class="nounderline abstract_t">Lang RM, Badano LP, Tsang W, et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr 2012; 25:3.</a></li><li><a class="nounderline abstract_t">Altiok E, Hamada S, Brehmer K, et al. Analysis of procedural effects of percutaneous edge-to-edge mitral valve repair by 2D and 3D echocardiography. Circ Cardiovasc Imaging 2012; 5:748.</a></li><li><a class="nounderline abstract_t">Nichol PM, Gilbert BW, Kisslo JA. Two-dimensional echocardiographic assessment of mitral stenosis. Circulation 1977; 55:120.</a></li><li><a class="nounderline abstract_t">Wann LS, Weyman AE, Feigenbaum H, et al. Determination of mitral valve area by cross-sectional echocardiography. Ann Intern Med 1978; 88:337.</a></li><li><a class="nounderline abstract_t">Hatle L, Brubakk A, Tromsdal A, Angelsen B. Noninvasive assessment of pressure drop in mitral stenosis by Doppler ultrasound. Br Heart J 1978; 40:131.</a></li><li><a class="nounderline abstract_t">Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation 1979; 60:1096.</a></li><li><a class="nounderline abstract_t">Tischler MD, Niggel J. Exercise echocardiography in combined mild mitral valve stenosis and regurgitation. Echocardiography 1993; 10:453.</a></li><li><a class="nounderline abstract_t">Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22:1.</a></li><li><a class="nounderline abstract_t">Kato N, Pislaru SV, Padang R, et al. A Novel Assessment Using Projected Transmitral Gradient Improves Diagnostic Yield of Doppler Hemodynamics in Rheumatic and Calcific Mitral Stenosis. JACC Cardiovasc Imaging 2021; 14:559.</a></li><li><a class="nounderline abstract_t">Reis G, Motta MS, Barbosa MM, et al. Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis. J Am Coll Cardiol 2004; 43:393.</a></li><li><a class="nounderline abstract_t">Zamorano J, Cordeiro P, Sugeng L, et al. Real-time three-dimensional echocardiography for rheumatic mitral valve stenosis evaluation: an accurate and novel approach. J Am Coll Cardiol 2004; 43:2091.</a></li><li><a class="nounderline abstract_t">Binder TM, Rosenhek R, Porenta G, et al. Improved assessment of mitral valve stenosis by volumetric real-time three-dimensional echocardiography. J Am Coll Cardiol 2000; 36:1355.</a></li><li><a class="nounderline abstract_t">Vainrib A, Massera D, Sherrid MV, et al. Three-Dimensional Imaging and Dynamic Modeling of Systolic Anterior Motion of the Mitral Valve. J Am Soc Echocardiogr 2021; 34:89.</a></li><li><a class="nounderline abstract_t">Abascal VM, Wilkins GT, O'Shea JP, et al. Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy. Circulation 1990; 82:448.</a></li><li><a class="nounderline abstract_t">Wilkins GT, Weyman AE, Abascal VM, et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988; 60:299.</a></li><li><a class="nounderline abstract_t">Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol 1993; 21:390.</a></li><li><a class="nounderline abstract_t">Himelman RB, Schiller NB. Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease. Am J Cardiol 1989; 63:347.</a></li><li><a class="nounderline abstract_t">Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017; 30:303.</a></li><li><a class="nounderline abstract_t">Carpentier A. Cardiac valve surgery--the "French correction". J Thorac Cardiovasc Surg 1983; 86:323.</a></li><li><a class="nounderline abstract_t">Coisne A, Aghezzaf S, Edmé JL, et al. Reproducibility of reading echocardiographic parameters to assess severity of mitral regurgitation. Insights from a French multicentre study. Arch Cardiovasc Dis 2020; 113:599.</a></li><li><a class="nounderline abstract_t">Himelman RB, Stulbarg MS, Lee E, et al. Noninvasive evaluation of pulmonary artery systolic pressures during dynamic exercise by saline-enhanced Doppler echocardiography. Am Heart J 1990; 119:685.</a></li><li><a class="nounderline abstract_t">Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38:2739.</a></li><li><a class="nounderline abstract_t">Magne J, Lancellotti P, Piérard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010; 122:33.</a></li><li><a class="nounderline abstract_t">Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987; 75:175.</a></li><li><a class="nounderline abstract_t">Utsunomiya T, Doshi R, Patel D, et al. Regurgitant volume estimation in patients with mitral regurgitation: initial studies using color Doppler "proximal isovelocity surface area" method. Echocardiography 1992; 9:63.</a></li><li><a class="nounderline abstract_t">Grayburn PA, Fehske W, Omran H, et al. Multiplane transesophageal echocardiographic assessment of mitral regurgitation by Doppler color flow mapping of the vena contracta. Am J Cardiol 1994; 74:912.</a></li><li><a class="nounderline abstract_t">Hall SA, Brickner ME, Willett DL, et al. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Circulation 1997; 95:636.</a></li><li><a class="nounderline abstract_t">Thomas L, Foster E, Schiller NB. Peak mitral inflow velocity predicts mitral regurgitation severity. J Am Coll Cardiol 1998; 31:174.</a></li><li><a class="nounderline abstract_t">Kamoen V, El Haddad M, De Backer T, et al. The Average Pixel Intensity Method and Outcome of Mitral Regurgitation in Mitral Valve Prolapse. J Am Soc Echocardiogr 2020; 33:54.</a></li><li><a class="nounderline abstract_t">Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16:777.</a></li><li><a class="nounderline abstract_t">Simpson IA, Shiota T, Gharib M, Sahn DJ. Current status of flow convergence for clinical applications: is it a leaning tower of "PISA"? J Am Coll Cardiol 1996; 27:504.</a></li><li><a class="nounderline abstract_t">Zoghbi WA, Asch FM, Bruce C, et al. Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2019; 32:431.</a></li><li><a class="nounderline abstract_t">Thomas L, Foster E, Hoffman JI, Schiller NB. The Mitral Regurgitation Index: an echocardiographic guide to severity. J Am Coll Cardiol 1999; 33:2016.</a></li><li><a class="nounderline abstract_t">Afonso L, Shokr M, Akintoye E, et al. Usefulness of the Mitral Regurgitation Severity Index to Assess the Severity of Chronic Mitral Regurgitation. Am J Cardiol 2017; 120:304.</a></li><li><a class="nounderline abstract_t">Avgeropoulou CC, Rahko PS, Patel AK. Reliability of M-mode, two-dimensional and Doppler echocardiography in diagnosing a flail mitral valve leaflet. J Am Soc Echocardiogr 1988; 1:433.</a></li><li><a class="nounderline abstract_t">Ogawa S, Mardelli TJ, Hubbard FE. The role of cross-sectional echocardiography in the diagnosis of flail mitral leaflet. Clin Cardiol 1978; 1:85.</a></li><li><a class="nounderline abstract_t">Cioffi G, Tarantini L, De Feo S, et al. Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure. Eur J Heart Fail 2005; 7:1112.</a></li><li><a class="nounderline abstract_t">Lancellotti P, Gérard PL, Piérard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005; 26:1528.</a></li><li><a class="nounderline abstract_t">Hayakawa M, Inoh T, Kawanishi H, et al. [Two-dimensional echocardiographic findings of patients with papillary muscle dysfunction]. J Cardiogr 1982; 12:137.</a></li><li><a class="nounderline abstract_t">Godley RW, Wann LS, Rogers EW, et al. Incomplete mitral leaflet closure in patients with papillary muscle dysfunction. Circulation 1981; 63:565.</a></li><li><a class="nounderline abstract_t">Kwan J, Shiota T, Agler DA, et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 2003; 107:1135.</a></li><li><a class="nounderline abstract_t">Wann LS, Feigenbaum H, Weyman AE, Dillon JC. Cross-sectional echocardiographic detection of rheumatic mitral regurgitation. Am J Cardiol 1978; 41:1258.</a></li></ol></div><div id="topicVersionRevision">Topic 5334 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Ultrasound cardiogram in mitral valve disease</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6016671" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Ultrasoundcardiography in mitral valve stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33332150" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8402769" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Transesophageal echocardiography in the evaluation of mitral regurgitation. The twenty-four signs of severe mitral regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6823848" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Normal left atrial function determined by 2-dimensional echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7795379" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Three-dimensional reconstruction of cardiac structures from transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30261961" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The Mitral Annulus Disjunction Arrhythmic Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9564922" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Accurate localization of mitral regurgitant defects using multiplane transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19356461" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Real-time 3-dimensional echocardiographic quantification of left ventricular volumes: multicenter study for validation with magnetic resonance imaging and investigation of sources of error.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22183020" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23001897" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Analysis of procedural effects of percutaneous edge-to-edge mitral valve repair by 2D and 3D echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/830199" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Two-dimensional echocardiographic assessment of mitral stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/629495" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Determination of mitral valve area by cross-sectional echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/637964" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Noninvasive assessment of pressure drop in mitral stenosis by Doppler ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/487543" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10146321" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Exercise echocardiography in combined mild mitral valve stenosis and regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19130998" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33582068" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A Novel Assessment Using Projected Transmitral Gradient Improves Diagnostic Yield of Doppler Hemodynamics in Rheumatic and Calcific Mitral Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15013120" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15172418" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Real-time three-dimensional echocardiography for rheumatic mitral valve stenosis evaluation: an accurate and novel approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11028494" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Improved assessment of mitral valve stenosis by volumetric real-time three-dimensional echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33059963" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Three-Dimensional Imaging and Dynamic Modeling of Systolic Anterior Motion of the Mitral Valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2372892" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3190958" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8426003" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2464278" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28314623" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6887954" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Cardiac valve surgery--the "French correction".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32994143" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Reproducibility of reading echocardiographic parameters to assess severity of mitral regurgitation. Insights from a French multicentre study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2309615" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Noninvasive evaluation of pulmonary artery systolic pressures during dynamic exercise by saline-enhanced Doppler echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28886619" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : 2017 ESC/EACTS Guidelines for the management of valvular heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20566950" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3791603" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Color Doppler assessment of mitral regurgitation with orthogonal planes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10149871" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Regurgitant volume estimation in patients with mitral regurgitation: initial studies using color Doppler "proximal isovelocity surface area" method.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7977120" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Multiplane transesophageal echocardiographic assessment of mitral regurgitation by Doppler color flow mapping of the vena contracta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9024151" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9426037" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Peak mitral inflow velocity predicts mitral regurgitation severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31619368" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The Average Pixel Intensity Method and Outcome of Mitral Regurgitation in Mitral Valve Prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12835667" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8557928" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Current status of flow convergence for clinical applications: is it a leaning tower of "PISA"?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30797660" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10362208" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The Mitral Regurgitation Index: an echocardiographic guide to severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28550931" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Usefulness of the Mitral Regurgitation Severity Index to Assess the Severity of Chronic Mitral Regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3078560" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Reliability of M-mode, two-dimensional and Doppler echocardiography in diagnosing a flail mitral valve leaflet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/756820" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The role of cross-sectional echocardiography in the diagnosis of flail mitral leaflet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15919238" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15814566" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7119489" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : [Two-dimensional echocardiographic findings of patients with papillary muscle dysfunction].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7460242" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Incomplete mitral leaflet closure in patients with papillary muscle dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12615791" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/665532" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Cross-sectional echocardiographic detection of rheumatic mitral regurgitation.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
